C-reactive protein and white blood cell levels in schizophrenia, bipolar disorders and depression - associations with mortality and psychiatric outcomes: a population-based study

European Psychiatry

Volumn 44, Issue , 2017, Pages 164-172

  Horsdal, H T ^a,b   Kohler Forsberg O ^b,c,d   Benros, M E ^b,d   Gasse, C ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Pro inflammatory markers; Psychoimmunology; Severe mental disorders

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CORTICOSTEROID; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; COMORBIDITY; CONTROLLED STUDY; DENMARK; DEPRESSION; FEMALE; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; MORTALITY; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; BLOOD; LEUKOCYTE; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; BIOMARKERS; BIPOLAR DISORDER; C-REACTIVE PROTEIN; DENMARK; DEPRESSIVE DISORDER; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RESEARCH DESIGN; SCHIZOPHRENIA;

EID: 85021176254     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2017.04.012     Document Type: Article

References (53)

1. Baumeister, D., Russell, A., Pariante, C.M., Mondelli, V., Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol 49 (2014), 841–849.
2. Benros, M.E., Nielsen, P.R., Nordentoft, M., Eaton, W.W., Dalton, S.O., Mortensen, P.B., Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168 (2011), 1303–1310.
3. Benros, M.E., Waltoft, B.L., Nordentoft, M., Ostergaard, S.D., Eaton, W.W., Krogh, J., et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70 (2013), 812–820.
4. Foldager, L., Kohler, O., Steffensen, R., Thiel, S., Kristensen, A.S., Jensenius, J.C., et al. Bipolar and panic disorders may be associated with hereditary defects in the innate immune system. J Affect Disord 164 (2014), 148–154.
5. Sekar, A., Bialas, A.R., de, R.H., Davis, A., Hammond, T.R., Kamitaki, N., et al. Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
6. Fernandes, B.S., Steiner, J., Bernstein, H.G., Dodd, S., Pasco, J.A., Dean, O.M., et al. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 21 (2016), 554–564.
7. Akanji, A.O., Ohaeri, J.U., Al-Shammri, S., Fatania, H.R., Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Psychiatry Res 169 (2009), 56–61.
8. Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Yang, S., et al. C-reactive protein is elevated in schizophrenia. Schizophr Res 143 (2013), 198–202.
9. Fawzi, M.H., Fawzi, M.M., Fawzi, M.M., Said, N.S., C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiatry Res 190 (2011), 91–97.
10. Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., et al. A significant causal association between C-reactive protein levels and schizophrenia. Sci Rep, 6, 2016, 26105.
11. Lin, C.C., Chang, C.M., Liu, C.Y., Huang, T.L., Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients. Asia Pac Psychiatry 5 (2013), E58–E63.
12. Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study. Schizophr Bull 40 (2014), 1117–1127.
13. De Berardis, D., Conti, C.M., Campanella, D., Carano, A., Scali, M., Valchera, A., et al. Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder. Int J Immunopathol Pharmacol 21 (2008), 319–324.
14. Dickerson, F., Stallings, C., Origoni, A., Boronow, J., Yolken, R., Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007), 952–955.
15. Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Yolken, R., Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord 150 (2013), 456–459.
16. Fernandes, B.S., Steiner, J., Molendijk, M.L., Dodd, S., Nardin, P., Goncalves, C.A., et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 3 (2016), 1147–1156.
17. Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Elevated C-reactive protein and late-onset bipolar disorder in 78,809 individuals from the general population. Br J Psychiatry 208 (2016), 138–145.
18. Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study. Biol Psychiatry 76 (2014), 249–257.
19. Wium-Andersen, M.K., Orsted, D.D., Nielsen, S.F., Nordestgaard, B.G., Elevated C-reactive protein levels, psychological distress, and depression in 73,131 individuals. JAMA Psychiatry 70 (2013), 176–184.
20. Liukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Rasanen, P., Leinonen, M., Meyer-Rochow, V.B., et al. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 60 (2006), 825–830.
21. Liu, Y., Al-Sayegh, H., Jabrah, R., Wang, W., Yan, F., Zhang, J., Association between C-reactive protein and depression: modulated by gender and mediated by body weight. Psychiatry Res 219 (2014), 103–108.
22. Wysokinski, A., Margulska, A., Strzelecki, D., Kloszewska, I., Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder. Nord J Psychiatry 69 (2015), 346–353.
23. Kohler, O., Sylvia, L.G., Bowden, C.L., Calabrese, J.R., Thase, M., Shelton, R.C., et al. White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. Aust N Z J Psychiatry, 2016.
24. Uher, R., Tansey, K.E., Dew, T., Maier, W., Mors, O., Hauser, J., et al. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171 (2014), 1278–1286.
25. Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane, V.A., Cleare, A.J., Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 25 (2015), 1532–1543.
26. Nordentoft, M., Wahlbeck, K., Hallgren, J., Westman, J., Osby, U., Alinaghizadeh, H., et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. Plos One, 8, 2013, e55176.
27. Pedersen, C.B., The Danish civil registration system. Scand J Public Health 39 (2011), 22–25.
28. Mors, O., Perto, G.P., Mortensen, P.B., The Danish psychiatric central research register. Scand J Public Health 39 (2011), 54–57.
29. Grann, A.F., Erichsen, R., Nielsen, A.G., Froslev, T., Thomsen, R.W., Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus university, Denmark. Clin Epidemiol 3 (2011), 133–138.
30. Lynge, E., Sandegaard, J.L., Rebolj, M., The Danish National Patient Register. Scand J Public Health 39 (2011), 30–33.
31. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
32. Reuter, M.B., Soegaard, B., Nordentoft, M., Erlangsen, A., Incidence rates of deliberate self-harm in Denmark 1994–2011. Crisis, 2016, 1–9.
33. Jensen, V.M., Rasmussen, A.W., Danish education registers. Scand J Public Health 39 (2011), 91–94.
34. Petersson, F., Baadsgaard, M., Thygesen, L.C., Danish registers on personal labour market affiliation. Scand J Public Health 39 (2011), 95–98.
35. Kildemoes, H.W., Sorensen, H.T., Hallas, J., The Danish National prescription registry. Scand J Public Health 39 (2011), 38–41.
36. Sundhedsstyrelsen, CfEoMT, Reference program for skizofreni. 2004, Sundhedsstyrelsen, København.
37. Uggerby, P., Ostergaard, S.D., Roge, R., Correll, C.U., Nielsen, J., The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good. Dan Med J, 60, 2013, A4578.
38. Bock, C., Bukh, J.D., Vinberg, M., Gether, U., Kessing, L.V., Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health, 5, 2009, 4.
39. Kessing, L., Validity of diagnoses and other clinical register data in patients with affective disorder. Eur Psychiatry 13 (1998), 392–398.
40. Andersen, C.L., Siersma, V.D., Karlslund, W., Hasselbalch, H.C., Felding, P., Bjerrum, O.W., et al. The Copenhagen primary care differential count (CopDiff) database. Clin Epidemiol 6 (2014), 199–211.
41. Hope, S., Melle, I., Aukrust, P., Steen, N.E., Birkenaes, A.B., Lorentzen, S., et al. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord 11 (2009), 726–734.
42. Vuksan-Cusa, B., Sagud, M., Jakovljevic, M., C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia. Psychiatr Danub 22 (2010), 275–277.
43. Woloshin, S., Schwartz, L.M., Distribution of C-reactive protein values in the United States. N Engl J Med 352 (2005), 1611–1613.
44. Kao, T.W., Lu, I.S., Liao, K.C., Lai, H.Y., Loh, C.H., Kuo, H.K., Associations between body mass index and serum levels of C-reactive protein. S Afr Med J 99 (2009), 326–330.
45. Lakryc, E.M., Machado, R.B., Soares, J.M. Jr., Fernandes, C.E. III, Baracat, E.C., What is the influence of hormone therapy on homocysteine and CRP levels in postmenopausal women?. Clinics (Sao Paulo) 70 (2015), 107–113.
46. Norouzi, V., Seifi, M., Fallah, S., Korani, M., Samadikuchaksaraei, A., Effect of oral contraceptive therapy on homocysteine and C-reactive protein levels in women: an observational study. Anadolu Kardiyol Derg 11 (2011), 698–702.
47. Diaz, F.J., Perez-Iglesias, R., Mata, I., Martinez-Garcia, O., Vazquez-Barquero, J.L., de, L.J., et al. Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naive psychotic sample. Schizophr Res 121 (2010), 207–212.
48. Barzilay, R., Lobel, T., Krivoy, A., Shlosberg, D., Weizman, A., Katz, N., Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior. Eur Psychiatry 31 (2016), 8–12.
49. Fan, X., Pristach, C., Liu, E.Y., Freudenreich, O., Henderson, D.C., Goff, D.C., Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res 149 (2007), 267–271.
50. Lagrand, W.K., Visser, C.A., Hermens, W.T., Niessen, H.W., Verheugt, F.W., Wolbink, G.J., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999), 96–102.
51. Li, Y., Zhong, X., Cheng, G., Zhao, C., Zhang, L., Hong, Y., et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis 259 (2017), 75–82.
52. Laursen, T.M., Wahlbeck, K., Hallgren, J., Westman, J., Osby, U., Alinaghizadeh, H., et al. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. Plos One, 8, 2013, e67133.
53. Balukova, S.M., Haarman, B.C., Riemersma-van der Lek, R.F., Schoevers, R.A., Does CRP predict outcome in bipolar disorder in regular outpatient care?. Int J Bipolar Disord, 4, 2016, 14.